Which has better valuation & earnings, QNT or CLBT?

Cellebrite DI has higher revenue and earnings than Quantinuum. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quantinuum $17.08M 798.82 N/A N/A N/A Cellebrite DI $475.67M 7.46 $78.33M $0.28 50.79

Does the media refer more to QNT or CLBT?

In the previous week, Quantinuum had 1 more articles in the media than Cellebrite DI. MarketBeat recorded 9 mentions for Quantinuum and 8 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.23 beat Quantinuum's score of 0.56 indicating that Cellebrite DI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quantinuum 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Cellebrite DI 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, NTNX or CLBT?

Nutanix has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than Nutanix, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nutanix $2.54B 5.86 $188.37M $0.95 57.94 Cellebrite DI $475.67M 7.46 $78.33M $0.28 50.79

Is NTNX or CLBT more profitable?

Cellebrite DI has a net margin of 14.48% compared to Nutanix's net margin of 10.03%. Cellebrite DI's return on equity of 18.38% beat Nutanix's return on equity. Company Net Margins Return on Equity Return on Assets Nutanix 10.03% -38.96% 8.55% Cellebrite DI 14.48% 18.38% 9.68%

Does the media prefer NTNX or CLBT?

In the previous week, Nutanix had 5 more articles in the media than Cellebrite DI. MarketBeat recorded 13 mentions for Nutanix and 8 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.23 beat Nutanix's score of 1.08 indicating that Cellebrite DI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nutanix 10 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cellebrite DI 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CHKP or CLBT?

In the previous week, Check Point Software Technologies had 11 more articles in the media than Cellebrite DI. MarketBeat recorded 19 mentions for Check Point Software Technologies and 8 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.23 beat Check Point Software Technologies' score of 1.06 indicating that Cellebrite DI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Check Point Software Technologies 10 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cellebrite DI 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, CLBT or PTC?

PTC has higher revenue and earnings than Cellebrite DI. PTC is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cellebrite DI $475.67M 7.46 $78.33M $0.28 50.79 PTC $2.74B 5.00 $734M $10.48 11.31

Is CLBT or PTC more profitable?

PTC has a net margin of 41.81% compared to Cellebrite DI's net margin of 14.48%. PTC's return on equity of 25.84% beat Cellebrite DI's return on equity. Company Net Margins Return on Equity Return on Assets Cellebrite DI 14.48% 18.38% 9.68% PTC 41.81% 25.84% 15.06%

Does the media refer more to CLBT or PTC?

In the previous week, PTC had 10 more articles in the media than Cellebrite DI. MarketBeat recorded 18 mentions for PTC and 8 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.23 beat PTC's score of 0.82 indicating that Cellebrite DI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cellebrite DI 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PTC 9 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, PINS or CLBT?

Pinterest has higher revenue and earnings than Cellebrite DI. Pinterest is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pinterest $4.22B 2.94 $416.86M $0.48 46.22 Cellebrite DI $475.67M 7.46 $78.33M $0.28 50.79

Does the media favor PINS or CLBT?

In the previous week, Pinterest had 14 more articles in the media than Cellebrite DI. MarketBeat recorded 22 mentions for Pinterest and 8 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.23 beat Pinterest's score of 1.03 indicating that Cellebrite DI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pinterest 15 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cellebrite DI 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cellebrite DI (CLBT) Competitors

$14.22 +0.16 (+1.14%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$14.48 +0.25 (+1.79%)

As of 07/24/2026 07:34 PM Eastern

Compare

CLBT vs. QNT, NTNX, CHKP, PTC, and PINS

Should you buy Cellebrite DI stock or one of its competitors? MarketBeat compares Cellebrite DI with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cellebrite DI include Quantinuum (QNT), Nutanix (NTNX), Check Point Software Technologies (CHKP), PTC (PTC), and Pinterest (PINS). These companies are all part of the "computer software" industry.

How does Cellebrite DI compare to Quantinuum?

Quantinuum (NASDAQ:QNT) and Cellebrite DI (NASDAQ:CLBT) are both computer software companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

45.9% of Cellebrite DI shares are held by institutional investors. 5.7% of Cellebrite DI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cellebrite DI has higher revenue and earnings than Quantinuum.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantinuum	$17.08M	798.82	N/A	N/A	N/A
Cellebrite DI	$475.67M	7.46	$78.33M	$0.28	50.79

Cellebrite DI has a net margin of 14.48% compared to Quantinuum's net margin of 0.00%. Cellebrite DI's return on equity of 18.38% beat Quantinuum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantinuum	N/A	N/A	N/A
Cellebrite DI	14.48%	18.38%	9.68%

Quantinuum presently has a consensus price target of $98.75, suggesting a potential upside of 88.85%. Cellebrite DI has a consensus price target of $21.40, suggesting a potential upside of 50.49%. Given Quantinuum's stronger consensus rating and higher possible upside, equities research analysts clearly believe Quantinuum is more favorable than Cellebrite DI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantinuum	0 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.86
Cellebrite DI	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

In the previous week, Quantinuum had 1 more articles in the media than Cellebrite DI. MarketBeat recorded 9 mentions for Quantinuum and 8 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.23 beat Quantinuum's score of 0.56 indicating that Cellebrite DI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantinuum	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Cellebrite DI	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cellebrite DI beats Quantinuum on 7 of the 12 factors compared between the two stocks.

How does Cellebrite DI compare to Nutanix?

Nutanix (NASDAQ:NTNX) and Cellebrite DI (NASDAQ:CLBT) are both computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership.

85.3% of Nutanix shares are held by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are held by institutional investors. 2.4% of Nutanix shares are held by insiders. Comparatively, 5.7% of Cellebrite DI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Nutanix presently has a consensus price target of $60.00, indicating a potential upside of 9.01%. Cellebrite DI has a consensus price target of $21.40, indicating a potential upside of 50.49%. Given Cellebrite DI's stronger consensus rating and higher possible upside, analysts clearly believe Cellebrite DI is more favorable than Nutanix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutanix	0 Sell rating(s)	8 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.56
Cellebrite DI	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Nutanix has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than Nutanix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutanix	$2.54B	5.86	$188.37M	$0.95	57.94
Cellebrite DI	$475.67M	7.46	$78.33M	$0.28	50.79

Cellebrite DI has a net margin of 14.48% compared to Nutanix's net margin of 10.03%. Cellebrite DI's return on equity of 18.38% beat Nutanix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutanix	10.03%	-38.96%	8.55%
Cellebrite DI	14.48%	18.38%	9.68%

In the previous week, Nutanix had 5 more articles in the media than Cellebrite DI. MarketBeat recorded 13 mentions for Nutanix and 8 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.23 beat Nutanix's score of 1.08 indicating that Cellebrite DI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutanix	10 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cellebrite DI	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nutanix has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market.

Summary

Cellebrite DI beats Nutanix on 9 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to Check Point Software Technologies?

Check Point Software Technologies (NASDAQ:CHKP) and Cellebrite DI (NASDAQ:CLBT) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Check Point Software Technologies has a net margin of 38.37% compared to Cellebrite DI's net margin of 14.48%. Check Point Software Technologies' return on equity of 38.79% beat Cellebrite DI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Check Point Software Technologies	38.37%	38.79%	16.80%
Cellebrite DI	14.48%	18.38%	9.68%

In the previous week, Check Point Software Technologies had 11 more articles in the media than Cellebrite DI. MarketBeat recorded 19 mentions for Check Point Software Technologies and 8 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.23 beat Check Point Software Technologies' score of 1.06 indicating that Cellebrite DI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Check Point Software Technologies	10 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cellebrite DI	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Check Point Software Technologies has higher revenue and earnings than Cellebrite DI. Check Point Software Technologies is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Check Point Software Technologies	$2.73B	4.89	$1.06B	$9.74	13.41
Cellebrite DI	$475.67M	7.46	$78.33M	$0.28	50.79

Check Point Software Technologies presently has a consensus target price of $150.52, indicating a potential upside of 15.28%. Cellebrite DI has a consensus target price of $21.40, indicating a potential upside of 50.49%. Given Cellebrite DI's stronger consensus rating and higher probable upside, analysts plainly believe Cellebrite DI is more favorable than Check Point Software Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Check Point Software Technologies	1 Sell rating(s)	16 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.33
Cellebrite DI	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Check Point Software Technologies has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market.

98.5% of Check Point Software Technologies shares are owned by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are owned by institutional investors. 29.0% of Check Point Software Technologies shares are owned by company insiders. Comparatively, 5.7% of Cellebrite DI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Check Point Software Technologies beats Cellebrite DI on 10 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to PTC?

Cellebrite DI (NASDAQ:CLBT) and PTC (NASDAQ:PTC) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

PTC has a net margin of 41.81% compared to Cellebrite DI's net margin of 14.48%. PTC's return on equity of 25.84% beat Cellebrite DI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cellebrite DI	14.48%	18.38%	9.68%
PTC	41.81%	25.84%	15.06%

Cellebrite DI has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market. Comparatively, PTC has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market.

45.9% of Cellebrite DI shares are held by institutional investors. Comparatively, 95.1% of PTC shares are held by institutional investors. 5.7% of Cellebrite DI shares are held by company insiders. Comparatively, 0.3% of PTC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Cellebrite DI currently has a consensus price target of $21.40, suggesting a potential upside of 50.49%. PTC has a consensus price target of $169.00, suggesting a potential upside of 42.59%. Given Cellebrite DI's stronger consensus rating and higher probable upside, equities analysts plainly believe Cellebrite DI is more favorable than PTC.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cellebrite DI	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83
PTC	1 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.53

PTC has higher revenue and earnings than Cellebrite DI. PTC is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cellebrite DI	$475.67M	7.46	$78.33M	$0.28	50.79
PTC	$2.74B	5.00	$734M	$10.48	11.31

In the previous week, PTC had 10 more articles in the media than Cellebrite DI. MarketBeat recorded 18 mentions for PTC and 8 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.23 beat PTC's score of 0.82 indicating that Cellebrite DI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cellebrite DI	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PTC	9 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

PTC beats Cellebrite DI on 9 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to Pinterest?

Pinterest (NYSE:PINS) and Cellebrite DI (NASDAQ:CLBT) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Pinterest presently has a consensus target price of $27.69, indicating a potential upside of 24.83%. Cellebrite DI has a consensus target price of $21.40, indicating a potential upside of 50.49%. Given Cellebrite DI's stronger consensus rating and higher probable upside, analysts plainly believe Cellebrite DI is more favorable than Pinterest.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pinterest	1 Sell rating(s)	18 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.44
Cellebrite DI	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Cellebrite DI has a net margin of 14.48% compared to Pinterest's net margin of 7.64%. Cellebrite DI's return on equity of 18.38% beat Pinterest's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pinterest	7.64%	8.26%	6.76%
Cellebrite DI	14.48%	18.38%	9.68%

Pinterest has higher revenue and earnings than Cellebrite DI. Pinterest is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pinterest	$4.22B	2.94	$416.86M	$0.48	46.22
Cellebrite DI	$475.67M	7.46	$78.33M	$0.28	50.79

88.8% of Pinterest shares are held by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are held by institutional investors. 8.1% of Pinterest shares are held by company insiders. Comparatively, 5.7% of Cellebrite DI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Pinterest has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market.

In the previous week, Pinterest had 14 more articles in the media than Cellebrite DI. MarketBeat recorded 22 mentions for Pinterest and 8 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.23 beat Pinterest's score of 1.03 indicating that Cellebrite DI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pinterest	15 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cellebrite DI	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cellebrite DI beats Pinterest on 9 of the 16 factors compared between the two stocks.

Get Cellebrite DI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CLBT vs. The Competition

Export

Metric	Cellebrite DI	INTERNET SOFTWARE Industry	Computer Sector	NASDAQ Exchange
Market Cap	$3.55B	$16.88B	$37.12B	$12.20B
Dividend Yield	N/A	1.75%	3.17%	9.41%
P/E Ratio	50.79	63.44	168.05	23.63
Price / Sales	7.46	33.87	596.19	111.98
Price / Cash	35.18	75.50	43.40	58.78
Price / Book	7.04	6.29	9.07	6.01
Net Income	$78.33M	$385.08M	$1.07B	$331.99M
7 Day Performance	-7.90%	-5.37%	-1.81%	-0.63%
1 Month Performance	3.34%	-2.58%	-3.68%	-3.04%
1 Year Performance	-0.70%	-19.85%	133.84%	13.30%

Cellebrite DI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CLBT Cellebrite DI	4.5941 of 5 stars	$14.22 +1.1%	$21.40 +50.5%	-0.7%	$3.55B	$475.67M	50.79	1,285	News Coverage Positive News
QNT Quantinuum	4.964 of 5 stars	$57.35 +2.3%	$98.75 +72.2%	N/A	$14.97B	$17.08M	N/A	704	Short Interest Decrease
NTNX Nutanix	3.0621 of 5 stars	$55.11 +0.1%	$60.00 +8.9%	-26.3%	$14.89B	$2.75B	58.01	7,800	News Coverage Positive News
CHKP Check Point Software Technologies	3.8168 of 5 stars	$135.73 -1.0%	$151.44 +11.6%	-40.7%	$14.48B	$2.73B	13.94	6,825	Upcoming Earnings Analyst Forecast Gap Down
PTC PTC	3.887 of 5 stars	$124.83 +0.4%	$171.27 +37.2%	-42.0%	$14.37B	$2.74B	11.91	7,642	News Coverage Upcoming Earnings Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CLBT) was last updated on 7/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cellebrite DI (CLBT) Competitors

CLBT vs. QNT, NTNX, CHKP, PTC, and PINS

How does Cellebrite DI compare to Quantinuum?

Summary

How does Cellebrite DI compare to Nutanix?

Summary

How does Cellebrite DI compare to Check Point Software Technologies?

Summary

How does Cellebrite DI compare to PTC?

Summary

How does Cellebrite DI compare to Pinterest?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLBT vs. The Competition

Cellebrite DI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cellebrite DI (CLBT) Competitors

CLBT vs. QNT, NTNX, CHKP, PTC, and PINS

How does Cellebrite DI compare to Quantinuum?

Do insiders and institutionals hold more shares of QNT or CLBT?

Which has better valuation & earnings, QNT or CLBT?

Is QNT or CLBT more profitable?

Do analysts prefer QNT or CLBT?

Does the media refer more to QNT or CLBT?

Summary

How does Cellebrite DI compare to Nutanix?

Do insiders & institutionals have more ownership in NTNX or CLBT?

Do analysts prefer NTNX or CLBT?

Which has stronger earnings and valuation, NTNX or CLBT?

Is NTNX or CLBT more profitable?

Does the media prefer NTNX or CLBT?

Which has more volatility & risk, NTNX or CLBT?

Summary

How does Cellebrite DI compare to Check Point Software Technologies?

Is CHKP or CLBT more profitable?

Does the media favor CHKP or CLBT?

Which has higher valuation & earnings, CHKP or CLBT?

Do analysts recommend CHKP or CLBT?

Which has more risk & volatility, CHKP or CLBT?

Do insiders and institutionals have more ownership in CHKP or CLBT?

Summary

How does Cellebrite DI compare to PTC?

Is CLBT or PTC more profitable?

Which has more risk & volatility, CLBT or PTC?

Do insiders and institutionals have more ownership in CLBT or PTC?

Do analysts recommend CLBT or PTC?

Which has higher valuation & earnings, CLBT or PTC?

Does the media refer more to CLBT or PTC?

Summary

How does Cellebrite DI compare to Pinterest?

Do analysts rate PINS or CLBT?

Is PINS or CLBT more profitable?

Which has stronger earnings and valuation, PINS or CLBT?

Do institutionals and insiders have more ownership in PINS or CLBT?

Which has more risk & volatility, PINS or CLBT?

Does the media favor PINS or CLBT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLBT vs. The Competition

Cellebrite DI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools